A former AstraZeneca Pharmaceuticals LP sales specialist can proceed with her claim that the company unlawfully fired her after refusing Covid-19 vaccination, a federal district court said.

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems have been reported.

Federal officials say the U.S. Food and Drug Administration (FDA) is reviewing reports of possible deaths in adults and ...

GSK GSK stock has risen 18.6% in the past three months. The price recovery was backed by strong third-quarter results, ...

The agency also is reviewing safety of immunizations for RSV, according to manufacturers of the therapies who have been ...

The FDA has informed Merck, Sanofi and AstraZeneca of the safety investigation into their RSV antibodies, though it remains ...

Federal health officials confirm a sweeping investigation into potential adult deaths linked to coronavirus immunizations.

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

FDA officials are newly scrutinizing several approved therapies to treat RSV in babies despite the fact that these shots were shown to be safe in clinical trials ...

The preventive therapies would be the latest called into question under U.S. Health Secretary Robert F. Kennedy Jr., a long-time promoter of anti-vaccine views.

As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...

U.S. regulators are reexamining infant RSV antibody treatments as safety questions surface, prompting new FDA scrutiny of ...